Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis

NCT04604652 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Biliary Cholangitis
Primary Biliary Cirrhosis
Cholangitis
Cholestasis
Biliary Tract Diseases
Bile Duct Stricture

Interventions

DRUG: HTD1801 (BUDCA)

Sponsor

HighTide Biopharma Pty Ltd